Workflow
NFTG(NFTG)
icon
Search documents
NFTG(NFTG) - 2025 Q1 - Quarterly Report
2025-05-15 20:30
Revenue and Expenses - For the three months ended March 31, 2025, the company generated revenues of $23,732, primarily from RNK Health, which provided non-clinical services amounting to $22,552[120] - Operating expenses for the same period increased by $371,569, or 35.6%, totaling $1,415,427 compared to $1,043,858 in the prior year[121] - General and administrative expenses totaled $1,194,438, reflecting an increase of $332,909, or 38.7%, compared to $861,529 in the previous year[123] - Research and development fees rose to $220,989, an increase of $38,660, or 21.2%, primarily due to costs associated with Gaxos Health[122] Net Loss and Cash Flow - The net loss for the three months ended March 31, 2025, was $1,232,062, an increase of $319,917, or 35.1%, from $912,145 in the same period of 2024[130] - The company reported a loss from operations of $1,391,695 for the three months ended March 31, 2025, an increase of $347,856, or 33.3%[128] - For the three months ended March 31, 2025, the net cash used in operations was $1,297,485, primarily due to a net loss of $1,232,062[134] - For the three months ended March 31, 2024, the net cash used in operations was $1,099,417, resulting from a net loss of $912,145[135] Investments and Financing Activities - For the three months ended March 31, 2025, net cash used in investing activities was $10,529,274, mainly from the purchase of short-term investments of $12,171,293[136] - For the three months ended March 31, 2024, net cash provided by investing activities was $349,602, resulting from proceeds from the sale of short-term investments of $2,616,619[137] - For the three months ended March 31, 2025, there were no cash flows from financing activities[138] - For the three months ended March 31, 2024, net cash provided by financing activities was $3,037,382, from a private placement of common stock and warrants[139] Future Outlook and Capital Needs - The company expects to continue generating operating losses in the foreseeable future due to corporate overhead and R&D costs[133] - The company believes existing working capital will meet operating needs and debt requirements for the next twelve months[133] - The company plans to pursue research and development of products, requiring additional capital from third-party sources[140] New Initiatives - The company launched Gaxos Labs in September 2024, focusing on generative AI services for game developers and publishers[109] - Gaxos Health, initiated in 2024, aims to provide AI-powered health optimization solutions, integrating biometric data with personalized wellness strategies[111] Accounting Standards - The company does not expect the adoption of new accounting standards to have a material impact on its consolidated financial statements[142]
NFTG(NFTG) - 2024 Q4 - Annual Report
2025-03-28 21:27
Revenue and Income - In 2024, the company generated revenues of $4,027 from health coaching packages, a significant increase from $256 in 2023[223] - The company reported other income of $279,322 in 2024, up from $67,188 in 2023, primarily from interest income and realized gains[232] - The company sold 1,449,277 common shares at $3.45 per share, generating net proceeds of $4,449,055 after fees[235] Expenses and Losses - Operating expenses decreased by $307,909, or 7.7%, from $4,015,541 in 2023 to $3,707,632 in 2024[224] - Research and development expenses increased by $80,669, or 8.8%, from $915,818 in 2023 to $996,487 in 2024, primarily due to costs associated with Gaxos Health[225] - General and administrative expenses totaled $2,711,145 in 2024, down from $3,047,360 in 2023, reflecting a decrease of $336,215[226] - The company reported a net loss of $3,424,283 in 2024, a decrease of $523,814, or 13.3%, from the net loss of $3,948,097 in 2023[233] - The company expects to continue generating operating losses in the foreseeable future due to corporate overhead and R&D costs[236] Cash Flow and Financial Position - As of December 31, 2024, the company had a cash balance of $14,398,099 and working capital of $16,427,618[234] - For the year ended December 31, 2024, net cash used in operations was $3,280,397, primarily due to a net loss of $3,424,283[237] - For the year ended December 31, 2023, net cash used in operations was $2,980,592, with a net loss of $3,948,097[238] - The company reported net cash provided by financing activities of $16,586,051 for the year ended December 31, 2024, mainly from common stock sales and warrant exercises[241] - The company had net cash provided by investing activities of $67,735 for the year ended December 31, 2024, from short-term investment sales[239] Strategic Initiatives - The company launched four proprietary games in 2023, enhancing user engagement through AI personalization and NFT minting[214] - Gaxos Health was initiated to provide AI-driven health optimization solutions, integrating biometric data for personalized wellness strategies[215] - RNK Health, a subsidiary formed in September 2024, focuses on marketing health-related products, holding a 70% membership interest[218] - The company plans to pursue research and development of new technologies, requiring additional capital beyond current resources[243] Shareholder Actions and Compliance - The company purchased and canceled 6,846 treasury shares for $19,602 at an average price of $2.86 per share in 2024[241] - The company had no off-balance sheet arrangements for the years ended December 31, 2024 and 2023[244] - The company intends to rely on exemptions available to emerging growth companies under the JOBS Act for compliance with new accounting standards[247]
NFTG(NFTG) - 2024 Q3 - Quarterly Report
2024-11-14 21:15
Revenue - Revenue for the three months ended September 30, 2024, was $2,704, primarily from health coaching packages, compared to no revenue in the same period of 2023[126] Operating Expenses - Operating expenses for the three months ended September 30, 2024, were $908,573, an increase of 4.0% from $873,616 in 2023[127] - Total operating expenses for the nine months ended September 30, 2024, decreased by 11.9% to $2,806,934 from $3,184,549 in 2023[127] - General and administrative expenses for the three months ended September 30, 2024, were $655,916, an increase of 6.6% from $615,211 in 2023[130] - Compensation and related benefits for the three months ended September 30, 2024, decreased by 17.2% to $172,502 from $208,365 in 2023[132] Research and Development - Research and development expenses for the three months ended September 30, 2024, were $252,657, a decrease of 2.2% from $258,405 in 2023[129] - The company expects to launch an AI solution for game developers in Q4 2024, aimed at transforming content generation in the gaming industry[117] Losses - For the three months ended September 30, 2024, the company reported a loss from operations of $905,869, an increase of $32,253, or 3.7% compared to the same period in 2023[138] - The net loss for the three months ended September 30, 2024, was $864,410, or $0.61 per common share, compared to a net loss of $857,059, or $0.85 per common share in the same period of 2023, reflecting an increase of $7,351, or 0.86%[141] - For the nine months ended September 30, 2024, the net loss was $2,585,793, a decrease of $561,341, or 17.8% compared to the same period in 2023[142] - The company anticipates continued operating losses in the foreseeable future due to corporate overhead and research and development costs[146] Cash and Financing - As of September 30, 2024, the company had a cash balance of $5,227,894 and working capital of $6,525,650[143] - The company raised aggregate gross proceeds of $3,499,484 from a private placement on March 13, 2024, with net proceeds of $3,056,984 after offering costs[144] - On September 20, 2024, the company received net proceeds of $2,834,843 from the exercise of March 2024 Common Warrants at a reduced exercise price, generating gross proceeds of $3,242,374[145] - For the nine months ended September 30, 2024, net cash used in operations was $2,512,166, primarily due to the net loss of $2,585,793[148] - The company reported net cash provided by financing activities of $5,872,746 for the nine months ended September 30, 2024, compared to $5,908,760 in the same period of 2023[152] Product Development - Gaxos Gaming launched four proprietary games by December 31, 2023, enhancing user experience through AI and NFT integration[114] - Gaxos Health initiative aims to provide AI-powered health optimization solutions, with a product launch expected in Q3 2024[118][119]
NFTG(NFTG) - 2024 Q2 - Quarterly Report
2024-08-13 20:30
Financial Performance - In the six months ended June 30, 2024, the company generated revenue of $19, compared to $0 in the same period of 2023[103]. - Operating expenses for the three months ended June 30, 2024, were $854,503, an increase of $85,902, or 11.2%, compared to $768,601 in 2023[104]. - Research and development expenses for the three months ended June 30, 2024, were $249,341, a decrease of $18,277, or 6.8%, compared to $267,618 in 2023[105]. - General and administrative expenses for the three months ended June 30, 2024, were $605,162, an increase of $156,542, or 34.9%, compared to $448,620 in 2023[106]. - The company reported a loss from operations of $854,503 for the three months ended June 30, 2024, an increase of $85,902, or 11.2%, compared to $768,601 in 2023[111]. - For the three months ended June 30, 2024, the net loss was $809,238, representing a 7.3% increase from the net loss of $754,044 in the same period of 2023[114]. - For the six months ended June 30, 2024, the net loss decreased to $1,721,383, a reduction of 24.8% compared to $2,290,075 for the same period in 2023[114]. Cash Flow and Financial Position - As of June 30, 2024, the company had a cash balance of $2,371,933 and short-term investments of $2,099,122, resulting in total working capital of $4,495,777[115]. - Net cash used in operations for the six months ended June 30, 2024, was $1,837,867, primarily due to the net loss adjusted for various expenses[118]. - Net cash provided by financing activities for the six months ended June 30, 2024, was $3,037,486, including net proceeds of $3,056,984 from a private placement[121]. - For the six months ended June 30, 2024, net cash provided by investing activities was $147,604, resulting from proceeds from the sale of short-term investments[120]. - The company plans to use the net proceeds from the private placement for general corporate purposes and working capital[116]. - The company believes that existing working capital and cash on hand will be sufficient to meet its operating needs for the next twelve months[117]. - The company has no off-balance sheet arrangements or commitments as defined in Item 303(a)(4)(ii) of Regulation S-K[124]. Future Plans and Initiatives - The company plans to launch more proprietary games in 2024, with a pipeline of games in various stages of development[93]. - An artificial intelligence solution for game developers is expected to launch in Q3 of 2024, aimed at enhancing creativity and integration in game development[94]. - Gaxos Health, a new initiative focused on AI-powered health optimization solutions, is expected to launch in the second half of 2024[95]. - The company expects to continue generating operating losses in the foreseeable future due to corporate overhead and research and development costs[117]. Other Income and Impairments - Other income for the three months ended June 30, 2024, was $45,265, an increase of $30,708, or 210.9%, compared to $14,557 in 2023[113]. - The company recorded an impairment loss of $52,363 during the six months ended June 30, 2023, due to the termination of a license agreement[110].
NFTG(NFTG) - 2024 Q1 - Quarterly Report
2024-05-14 20:30
Revenue and Financial Performance - Revenue for the three months ended March 31, 2024, was $19, compared to $0 in the same period of 2023[115] - Net loss for Q1 2024 was $912,145, a decrease of $623,886, or 40.6%, compared to a net loss of $1,536,031 in Q1 2023[125] Operating Expenses - Operating expenses decreased by $498,493, or 32.3%, from $1,542,332 in Q1 2023 to $1,043,858 in Q1 2024[116] - General and administrative expenses decreased from $1,437,781 in Q1 2023 to $861,529 in Q1 2024, a decrease of $576,252, or 40.1%[119] - Research and development expenses increased by $77,778, or 74.4%, from $104,551 in Q1 2023 to $182,329 in Q1 2024[118] Cash Flow and Investments - Cash balance as of March 31, 2024, was $3,312,277, with short-term investments of $2,092,078 and working capital of $5,251,505[126] - Net cash used in operations for Q1 2024 was $1,099,417, compared to $933,858 in Q1 2023[129][130] - Net cash provided by investing activities for Q1 2024 was $349,602, resulting from proceeds from the sale of short-term investments[131] - For the three months ended March 31, 2024, net cash provided by financing activities was $3,037,382, compared to $5,958,470 for the same period in 2023, representing a decrease of approximately 49.1%[133][134] Financing and Capital Requirements - The company anticipates requiring significant capital to sustain operations and execute its long-term business plan, indicating a reliance on additional debt or equity financing if revenue generation is insufficient[135] - The net proceeds from the IPO closed in February 2023 are expected to be sufficient to meet financial obligations for at least the next 12 months[135] - The company entered into a securities purchase agreement for the issuance of 108,000 shares of common stock and warrants, with a purchase price of $5.57 per share, resulting in aggregate net proceeds of $3,056,984 after expenses[133] - The company purchased and cancelled 6,846 treasury shares for $19,602, averaging $2.86 per share during the three months ended March 31, 2024[133] Regulatory and Compliance - The company has no off-balance sheet arrangements or commitments as defined in Regulation S-K[136] - The company is taking advantage of the extended transition periods under the JOBS Act for complying with new accounting standards, which may affect comparability with other public companies[138] - As an "emerging growth company," the company intends to rely on certain exemptions under the JOBS Act, including auditor's attestation reports on internal controls[139] - The company is classified as a "smaller reporting company" and is not required to provide certain market risk disclosures[140] Future Plans - The company plans to launch more games in 2024 and has a pipeline of games in various stages of development[103] - Gaxos Health is expected to launch its AI-powered health optimization product in the second half of 2024[108]
NFTG(NFTG) - 2023 Q4 - Annual Report
2024-03-27 21:29
Financial Performance - In 2023, the company generated revenue of $256, compared to $0 in 2022, indicating initial revenue generation from operations [217]. - Operating expenses increased to $4,015,541 in 2023 from $1,424,096 in 2022, representing a rise of 182.0% [218]. - The net loss for 2023 was $3,948,097, an increase of 177.8% from the net loss of $1,421,172 in 2022 [228]. - The company reported a net loss of $1,421,172 for the year ended December 31, 2022, with net cash used in operations amounting to $1,260,425 [234]. Research and Development - Research and development fees rose by 11.1% to $915,818 in 2023, primarily due to increased labor and outside development costs [219]. - The company plans to pursue research and development of products, requiring additional capital from third-party sources [239]. Cash and Investments - As of December 31, 2023, the company had a cash balance of $1,024,710 and short-term investments of $2,592,689, totaling working capital of $3,372,503 [230]. - For the year ended December 31, 2023, net cash used in investing activities was $2,533,213, primarily due to the purchase of short-term investments totaling $3,491,242 [235]. Future Plans - The company plans to launch more games in 2024, with a pipeline of games in various stages of development [207]. - An artificial intelligence solution for game developers is expected to launch in Q2 of 2024 [208]. - Gaxos Health, a new initiative, aims to launch AI-powered health optimization products in the second half of 2024 [210]. Shareholder Actions - During the year ended December 31, 2023, the company purchased and cancelled 244,184 treasury shares for $99,736, averaging $0.408 per share [237]. - The IPO closed on February 17, 2023, resulting in gross proceeds of approximately $7 million and net proceeds of $5,958,470 after expenses [237]. Financial Obligations and Capital Needs - The company will require significant amounts of capital to sustain operations and execute its long-term business plan [239]. - The company intends to rely on exemptions under the JOBS Act as an "emerging growth company" until certain revenue or debt thresholds are met [244]. - The company had no off-balance sheet arrangements or commitments for the years ended December 31, 2023 and 2022 [241]. Other Financial Metrics - The company recorded an impairment loss of $52,363 in 2023 due to the termination of a software and patent license agreement [225]. - The increase in accounts payable was $148,761, and accrued expenses increased by $8,197 for the year ended December 31, 2022 [234]. - The company experienced a decrease of $400 in prepaid expenses and other current assets, contributing to the net cash used in operations [234].
NFTG(NFTG) - 2023 Q3 - Quarterly Report
2023-11-14 21:00
Game Development and User Engagement - As of September 30, 2023, the company launched two games, Space Striker AI and Brawl Bots, enhancing user engagement through unique gameplay experiences[89] - The company aims to develop a robust digital gaming platform, Gaxos, integrating various game genres and NFT features[91] - The company’s NFTs are powered by the Polygon blockchain, providing users with unique in-game assets[90] Financial Position and Cash Management - The company reported approximately $437,000 in cash exceeding FDIC limits of $250,000 as of September 30, 2023[100] - As of September 30, 2023, the Company had cash of $764,977 and short-term investments of $3,570,888, consisting of marketable debt securities[130] - The company held 1,565 units of Polygon (MATIC) as digital currencies as of September 30, 2023, with no holdings as of December 31, 2022[104] Investments and Asset Valuation - The company's short-term investments totaled $3,570,888 as of September 30, 2023, with unrealized gains of $41,841 for the three months ended September 30, 2023[97][103] - The company evaluates its investments for other-than-temporary declines in fair value each quarter, ensuring accurate asset valuation[102] Revenue Recognition and Financial Reporting - The company follows ASC Topic 606 for revenue recognition, ensuring accurate reporting of revenue from customer contracts[109] - The company’s financial statements are prepared in accordance with GAAP and SEC requirements, reflecting its financial condition and operations[93] Research and Development Expenses - The Company reported research and development fees of $258,405 for the three months ended September 30, 2023, an increase of 17.0% compared to $220,902 in the same period of 2022[120] - The Company expects research and development fees to increase in the future as the development of games accelerates[120] Operating Loss and Financial Performance - The Company incurred a net loss of $857,059 for the three months ended September 30, 2023, representing an increase of 162.57% from a net loss of $326,198 in the same period of 2022[129] - The loss from operations for the three months ended September 30, 2023, was $873,616, an increase of 167.5% compared to $326,552 in the same period of 2022[127] - The Company generated a net loss of $3,147,134 for the nine months ended September 30, 2023, compared to a net loss of $1,098,130 for the same period in 2022, an increase of 186.6%[129] - Cash used in operations for the nine months ended September 30, 2023, was $2,307,697, primarily due to the net loss of $3,147,134[133] Financing Activities and Capital Needs - Net cash provided by financing activities for the nine months ended September 30, 2023, was $5,908,760, following an IPO that raised approximately $7 million[137] - The company anticipates needing significant capital to sustain operations and execute its long-term business plan, particularly for new technologies[139] - The company believes that the net proceeds from the IPO that closed in February 2023 will be sufficient to meet its financial obligations for at least the next 12 months[139] Regulatory and Market Considerations - The Inflation Reduction Act of 2022 imposes a new 1% excise tax on stock repurchases by publicly traded U.S. corporations starting January 1, 2023[141] - The company continues to evaluate the impact of the COVID-19 pandemic, noting potential negative effects on its financial position and operations[142] - As of September 30, 2023, the company did not have any off-balance sheet arrangements or commitments[144] - The company intends to rely on exemptions provided under the JOBS Act as an "emerging growth company" until certain revenue or debt thresholds are met[147] Software Development Costs - The company capitalized $24,625 in internal-use software development costs during the three months ended September 30, 2023, to be amortized over 36 months[105]
NFTG(NFTG) - 2023 Q2 - Quarterly Report
2023-08-14 20:01
Gaming Platform Development - The company is developing a gaming platform called "Gaxos," which will integrate conventional games with unique in-game features represented as NFTs[89] - The initial launch will focus on proprietary games that allow users to mint affordable NFTs with exclusive features[90] Financial Position - As of June 30, 2023, the company held approximately $1,171,000 in cash exceeding FDIC limits of $250,000[102] - As of June 30, 2023, the company had $1,688,910 in cash and $3,529,047 in short-term investments[133] - The accumulated deficit as of June 30, 2023, was $3,723,502[134] Revenue Generation - Revenue will be generated from the sale of in-game NFTs, recognized upon delivery to customers, with payments accepted in both USD and digital currencies[112] - Advertising fees from game advertisers and developers will also contribute to revenue, recognized ratably over the service period[113] - No revenue was generated from operations during the three and six months ended June 30, 2023, and 2022, with no revenue anticipated for the foreseeable future[120] Expenses and Losses - Research and development fees for the three months ended June 30, 2023, were $267,618, an increase of $30,250, or 12.7% compared to the same period in 2022[123] - General and administrative expenses for the three months ended June 30, 2023, totaled $448,620, an increase of $221,377, or 97.4% compared to the same period in 2022[124] - Compensation and related benefits increased to $207,597 for the three months ended June 30, 2023, representing a 32.6% increase from $156,523 in the same period in 2022[125] - The net loss for the three months ended June 30, 2023, was $754,044, a 62.5% increase from the net loss of $464,094 in the same period in 2022[132] - Cash used in operations for the six months ended June 30, 2023, was $1,433,858, primarily due to a net loss of $2,290,075[136] Cash Flow Activities - Net cash used in investing activities for the six months ended June 30, 2023, was $3,491,242, resulting from the purchase of short-term investments[138] - Net cash provided by financing activities for the six months ended June 30, 2023, was $5,934,229, following an IPO that raised approximately $7 million[139] Compliance and Reporting - The financial statements are prepared in accordance with GAAP and SEC requirements[94] - The company has no capitalized software costs as of June 30, 2023, with all development costs expensed as incurred[107] - The company intends to rely on exemptions as an "emerging growth company" until total annual gross revenues reach $1.07 billion or more[148] - The company will remain an "emerging growth company" until the last day of the fiscal year following the fifth anniversary of its initial public offering[148] - The company is classified as a "smaller reporting company" and is not required to provide certain market risk disclosures[149] Investment Evaluation - The company plans to evaluate its investments for other-than-temporary declines in fair value each quarter[104]
NFTG(NFTG) - 2023 Q1 - Quarterly Report
2023-05-12 20:01
Gaming Platform Development - The company is developing a gaming platform called "Gaxos," which will integrate conventional games with unique in-game features as non-fungible tokens (NFTs) to enhance user experiences [88]. - The company plans to launch proprietary games that allow gamers to mint affordable NFTs with unique features, usable across its network of games [89]. Financial Position - As of March 31, 2023, the company had approximately $1,556,000 in cash exceeding the FDIC limit of $250,000 [101]. - As of March 31, 2023, the company had cash of $2,213,151 and short-term investments of $3,509,398, totaling $5,722,549 in liquid assets [132]. - The accumulated deficit as of March 31, 2023, was $2,969,458, indicating ongoing financial challenges [133]. - The company expects to require significant capital to sustain operations and execute its long-term business plan, indicating a need for additional financing [140]. Revenue Generation - Revenue will be generated from the sale of in-game NFTs, recognized upon delivery to customers, with payments accepted in both USD and digital currencies [113]. - The company plans to generate revenue from advertising fees, recognized ratably over the agreed advertising service period [117]. - Royalty revenues will be recognized when it is probable that the company will collect the fee owed, typically upon notification of an NFT sale on a third-party platform [117]. - Transaction fee revenues will be recognized on the date of the respective transaction, with current transaction fees being negligible [117]. Research and Development - Research and development costs are expensed as incurred, including labor and outside development costs [114]. - Research and development fees decreased to $104,551 for the three months ended March 31, 2023, from $150,495 in the same period of 2022, a decrease of 30.6% [124]. Operational Performance - For the three months ended March 31, 2023, the company reported no revenue from operations and does not anticipate generating revenue in the foreseeable future [121]. - The company reported a loss from operations of $1,542,332 for the three months ended March 31, 2023, compared to a loss of $308,209 in the same period of 2022, an increase of 400.5% [129]. - The net loss for the three months ended March 31, 2023, was $1,536,031, or a net loss per common share of $0.14, compared to a net loss of $307,838, or $0.03 per share, in the same period of 2022, an increase of 399.5% [131]. - Net cash used in operations for the three months ended March 31, 2023, was $933,858, compared to $185,405 in the same period of 2022 [135]. IPO and Financing - The company closed an IPO on February 17, 2023, issuing 1,686,747 shares for gross proceeds of approximately $7 million and net proceeds of $5,958,470 [138]. Other Financial Metrics - The company recorded $18,156 of unrealized gains as a component of other comprehensive loss for the three months ended March 31, 2023 [105]. - The company accounts for digital currencies and other digital assets as indefinite-lived intangible assets at historical cost, with no such assets held as of March 31, 2023 [106]. - General and administrative expenses increased significantly to $1,437,781 for the three months ended March 31, 2023, compared to $157,714 in the same period of 2022, an increase of 811.5% [125].
NFTG(NFTG) - 2022 Q4 - Annual Report
2023-03-31 20:01
Revenue Generation - The company did not generate any revenues from operations during the year ended December 31, 2022, and for the period from October 27, 2021, to December 31, 2021[251]. - The company anticipates that it will not generate revenue for the foreseeable future until a critical mass of users is achieved[251]. - The company plans to generate revenue from the sale of in-game NFTs, advertising fees, royalty revenues, commission from third-party sales, and transaction fees[244][247]. Research and Development - Research and development fees increased to $824,523 in 2022 from $6,810 in 2021, an increase of approximately $817,713 due to labor and outside development costs[254]. - The company expects research and development fees to increase in the future as the development of games accelerates[254]. - The company plans to capitalize development and production service payments to third-party developers as internal-use software development costs and licenses[253]. - The company plans to pursue research and development of its products, requiring significant capital beyond current resources[267]. Financial Condition - The company has no cash equivalents as of December 31, 2022, and 2021, and held approximately $1,578,000 in cash exceeding FDIC limits as of December 31, 2021[234][236]. - As of December 31, 2022, the company had approximately $679,781 in cash and an accumulated deficit of approximately $1.4 million[262]. - The company has not experienced any losses on its invested cash to date, but any loss or lack of access to funds could significantly impact its financial condition[235]. Expenses - General and administrative expenses for the year ended December 31, 2022, totaled $599,573, a significant increase from $5,445 in 2021[255]. - Compensation and related benefits increased to $369,914 in 2022 from $0 in 2021, due to the hiring of executive officers and employees[256]. - Professional fees rose to $164,495 in 2022, primarily due to accounting, legal, and recruiting fees associated with the IPO[257]. Losses - The company reported a loss from operations of $1,424,096 for the year ended December 31, 2022, compared to a loss of $12,255 in 2021, reflecting an increase of $1,411,841[259]. - Net loss for the year ended December 31, 2022, was $1,421,172, or $0.14 per common share, compared to a net loss of $12,255, or $0.00 per common share, in 2021[261]. - Net cash used in operations for the year ended December 31, 2022, was $1,260,425, primarily due to the net loss adjusted for changes in operating assets and liabilities[263]. IPO and Investments - The company closed its IPO on February 17, 2023, issuing 1,686,747 shares for gross proceeds of approximately $7 million, with net proceeds of $5.9 million[266]. - The company incurred net cash used in investing activities of $62,836 in 2022, related to a software and patent license agreement[264]. Digital Assets - The company accounts for digital currencies and other digital assets as indefinite-lived intangible assets at historical cost[237]. - The company plans to launch its gaming platform "Gaxos," which will allow users to mint unique in-game NFTs[224][225].